Botulinum Toxin Treatment in a Patient with Frey Syndrome After Upper Thoracic Sympathicotomy.
- Author:
Kwang Ho HAN
1
;
Chang Hun HUH
;
Koo Il SEO
;
Hee Chul EUN
Author Information
1. Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea. hceun@snu.ac.kr
- Publication Type:Case Report
- Keywords:
Frey syndrome;
Botulinum toxin type A
- MeSH:
Adult;
Botulinum Toxins*;
Botulinum Toxins, Type A;
Burns;
Eating;
Flushing;
Follow-Up Studies;
Humans;
Hyperhidrosis;
Sensation;
Sweat;
Sweating;
Sweating, Gustatory*
- From:Korean Journal of Dermatology
2001;39(9):1027-1030
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Frey syndrome is characterized by profuse facial sweating which is provoked by the taste of food. It has been described as a consequence of upper thoracic sympathicotomy. Botulinum toxin injection is a relatively new treatment modality for Frey syndrome. Botulinum toxin type A (Botox , Allergan, USA) had been successfully used to treat Frey syndrome occurring in a 38-year-old patient following thoracic sympathicotomy for palmar hyperhidrosis. A total dose of 100U of botulinum toxin (1.0U/0.1ml/cm2) injection resulted in a 6 months' resolution of sweating, burning, and flushing sensation on eating. During the follow-up period, no systemic side effects were experienced.
